Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AP1S1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | BAIAP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | MYL9 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | GOT2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | KDR | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | FBXL6 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | SPRED1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | CLN6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | RAP2B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | AARS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |